Latest News and Press Releases
Want to stay updated on the latest news?
-
PRISM MarketView Spotlights Opus Genetics in New Q&A with CEO George Magrath
-
Lipella Pharmaceuticals Reports Positive Topline Phase 2a Results for LP-310 in the Treatment of Oral Lichen Planus
-
Halberd Update on WatchDawg® PTSD Treatment
-
Lewes, Delaware, Nov. 25, 2024 (GLOBE NEWSWIRE) -- The Global Stem Cell Therapy Market Size is projected to grow at a CAGR of 13.95% from 2024 to 2030, according to a new report published by...
-
Toronto, Ontario, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The Canadian Epilepsy Alliance, national physician groups representing neurologists, epileptologists and other healthcare professionals, patients...
-
Lipella Pharmaceuticals Announces Completion of First Cohort in Phase 2a Trial of LP-310 for Oral Lichen Planus, Advancing to Next Dose Group
-
Strong Clinical Momentum for Soligenix's HyBryte™ in Treating Cutaneous T-Cell Lymphoma; PCG Digital Exclusive with Dr. Brian Poligone
-
Peru, IN, May 28, 2024 (GLOBE NEWSWIRE) -- The National Library of Medicine's recent reports underline a grim reality: a rise in drug-related overdoses, mainly linked to illicit opioids in Indiana....
-
WASHINGTON, Sept. 05, 2023 (GLOBE NEWSWIRE) -- As per Vantage Market Research, the Global Medical Tourism Market has rapidly grown over the years due to the increasing availability of affordable and...
-
New York, United States, Nov. 01, 2022 (GLOBE NEWSWIRE) -- The medical tourism market’s most prominent driver is the emergence of affordable healthcare choices, with increased quality services....